Abstracts

SARS-CoV-2 SPIKE PROTEIN DESTABILIZES MICROVASCULAR HOMEOSTASIS

SARS-CoV-2 infection can compromise respiratory function and cause thrombotic events. SARS-CoV-2 binds to and mediates downregulation of angiotensin converting enzyme 2 (ACE2) on infected cells. Diminished enzymatic activity of ACE2 could result in increased concentrations of the pro-inflammatory molecules angiotensin II and bradykinin, contributing to SARS-CoV-2 pathology. Immunofluorescence microscopy and digital image data quantification, Computer…

SARS-CoV-2 SPIKE EXPRESSION AT THE SURFACE OF INFECTED HUMAN AIRWAY EPITHELIAL CELLS

Emerging evidence points out to potential benefits from Fc-mediated effector functions in SARS-CoV-2 infection. Some Fc-mediated effector functions such as antibody-dependent cellular cytotoxicity (ADCC) or antibody-dependent cellular phagocytosis (ADCP) require recognition of the antigen at the surface of infected cells. To evaluate the expression levels of SARS-CoV-2 Spike at the surface of infected airway epithelial…

RESTRICTED INFECTION OF MACROPHAGES BY SARS-CoV-2 INDUCES PROINFLAMMATORY RESPONSES

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with immune hyperactivation and high levels of proinflammatory cytokines. Extensive lung infiltration by CD169+ inflammatory monocytes and presence of activated CD169+ alveolar macrophages suggest monocyte/macrophages are key drivers of severe morbidity and mortality. In this study, we determined whether CD169 mediated ACE2-independent SARS-CoV-2 entry and…

THE EFFECTS OF TYPE I & II IFNs DISCLOSE A ROLE FOR DOPAMINE IN SARS-CoV-2 INFECTION

Recent studies highlight the dynamic nature of virus-host interaction during SARS-CoV-2 infection, raising intriguing questions about the role and timing of interferon (IFN) responses. In fact, SARS-CoV-2 delays/antagonizes Type-I, and to a definitely lesser extent, Type II-IFNs. While paving the way for potential antiviral therapies based on immune activation, the molecular mechanisms linking different IFN…

QUANTIFYING SARS-CoV-2 INFECTION KINETICS FROM UNVACCINATED AND VACCINATED PERSONS

Transmission of SARS-CoV-2 is highly heterogeneous, with a small fraction of infected individuals (often referred to as ‘superspreaders’) contributing a disproportionate share of forward transmission. Numerous behavioral and environmental explanations have been offered to explain transmission heterogeneity, but the extent to which the underlying features of the infection process within individual hosts contribute towards the…

MUTATIONS IN PERSISTENT SARS?COV?2 CASES

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with decreased susceptibility to neutralizing antibodies are of clinical importance. While several demographic and clinical correlates of Coronavirus Disease 2019 (COVID-19) outcome have been identified, their relationship to virological and immunological parameters remain poorly defined. Here, we evaluate viral diversity and the accumulation of…

ORF1 REGION OF SARS-CoV-2 GENOMIC RNA AS A PROMISING TARGET FOR siRNA-BASED THERAPY

A promising approach to tackle the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) could be small interfering (si)RNAs. However, it is unclear so far, which viral replication steps can be efficiently inhibited with siRNAs. Here we report the first-ever in-depth analysis of RNAi-accessible SARS-CoV-2 replication steps. siRNAs were designed against four genomic regions of SARS-CoV-2. Initial…